The fund invests in early stages — pre-seed (idea, prototype) and seed (MVP, preclinical data) projects.
Investment format: unsecured convertible loans, providing flexibility for startups.
Expert support: mentoring, industry analysis, market entry assistance, access to infrastructure and clinical partners through the Artgen Biotech ecosystem.
Partner network / industrial partnerships: cooperation with universities, clinics, and technoparks; access to clinical trials and hypothesis testing in real-world medical environments.
Services provided
Funding: base volume of funds up to ~150 million rubles for three years, with the possibility of expansion.Investment format: unsecured convertible loans, providing flexibility for startups.
Expert support: mentoring, industry analysis, market entry assistance, access to infrastructure and clinical partners through the Artgen Biotech ecosystem.
Partner network / industrial partnerships: cooperation with universities, clinics, and technoparks; access to clinical trials and hypothesis testing in real-world medical environments.
Website: https://artgenseedfund.ru/
Email: seedfund@artgen.ru
Phone: +7 (495) 646-80-76
Contact persons:
• Press Secretary: Elena Romanova — rea@gemabank.ru
• Investment Director: Dmitry Krasotkin — ir@hsci.ru
Email: seedfund@artgen.ru
Phone: +7 (495) 646-80-76
Contact persons:
• Press Secretary: Elena Romanova — rea@gemabank.ru
• Investment Director: Dmitry Krasotkin — ir@hsci.ru
Similar innovation and technology infrastructure facilities
